ArticleFrontiers in cardiovascular medicine2026
hTERT associates with Rab7A to enhance autophagy and rescue oxLDL induced endothelial dysfunction.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endothelial dysfunction is a hallmark of atherosclerosis, driven by chronic exposure to oxidized LDL and linked to impaired autophagy. Although restoring autophagy in atherosclerosis has been shown to yield protective effects, the mechanisms contributing to dysregulated autophagy are unknown. Apart from previously known extra telomeric role in regulating inflammation, emerging evidence suggests a strong direct correlation between hTERT and autophagy pathway, however, potential molecular mechanisms still remain unknown. This study investigates hTERT's extra-telomeric function in rescuing oxLDL-induced endothelial dysfunction via autophagy regulation. Methods: hTERT was ectopically overexpressed or knocked down in oxLDL treated HUVEC cells to study its effect in endothelial dysfunction using oxLDL retention, monocyte attachment, endothelial resistance and barrier breach assays. Autophagy-related gene expression and autophagy dynamics were evaluated through qPCR, western blotting, live-cell imaging, immunofluorescence, and co-immunoprecipitation. Results: OxLDL-induced endothelial dysfunction reduced hTERT expression and increased ICAM1 levels. Pharmacological inhibition of hTERT with MST312 upregulated ICAM1 indicating induction of endothelial dysfunction. Ectopic hTERT expression rescued endothelial dysfunction, demonstrated by reduced intracellular oxLDL levels, decreased monocyte adhesion, improved barrier integrity, and increased TEER. Conversely, hTERT knockdown exacerbated these dysfunction markers. Mechanistically, hTERT enhanced autophagy gene expression and kinetics, with hTERT blockade reducing lysosome abundance. hTERT colocalized and associated with Rab7A under basal conditions, with enhanced association following oxLDL exposure. Conclusion: This study highlights a novel additional role of extra telomeric hTERT in contributing to endothelial resilience against atherogenic stress by rescuing endothelial dysfunction via enhancing the expression of autophagy-related gene expression and enhancing autophagy dynamics by associating with Rab7A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.